Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "manufacturing-facility"

631 News Found

AstraZeneca plans $1.5 billion ADCs manufacturing facility in Singapore
News | May 22, 2024

AstraZeneca plans $1.5 billion ADCs manufacturing facility in Singapore

Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs


Jubilant Pharmova announces completion of USFDA audit of Radiopharmaceuticals manufacturing facility at Montreal
Drug Approval | April 28, 2024

Jubilant Pharmova announces completion of USFDA audit of Radiopharmaceuticals manufacturing facility at Montreal

The USFDA has issued 5 observations pursuant to the completion of audit


Moderna pauses plan to build mRNA manufacturing facility in Kenya
News | April 16, 2024

Moderna pauses plan to build mRNA manufacturing facility in Kenya

The demand in Africa for COVID-19 vaccines has declined


Aragen operationalizes first phase of its US$ 30 million Biologics manufacturing facility in India
News | March 30, 2024

Aragen operationalizes first phase of its US$ 30 million Biologics manufacturing facility in India

Executes the first project for developing and manufacturing a novel anticancer mAb


Remedium Lifecare to acquire manufacturing facility in Hyderabad
News | March 08, 2024

Remedium Lifecare to acquire manufacturing facility in Hyderabad

The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes


Thermo Fisher receives AIFA’s GMP approval for manufacturing facility of RNA-based products in Italy
News | January 22, 2024

Thermo Fisher receives AIFA’s GMP approval for manufacturing facility of RNA-based products in Italy

GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients


Alkem completes sale of St. Louis manufacturing facility for US$ 7.96 million
News | December 31, 2023

Alkem completes sale of St. Louis manufacturing facility for US$ 7.96 million

The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year


Ami Organics inaugurates new API manufacturing facility
News | December 17, 2023

Ami Organics inaugurates new API manufacturing facility

This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment


Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma
News | December 03, 2023

Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma

The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene